Physical exercise attenuates obesity development in Western-diet fed obese rats independently of vitamin D supplementation
Carregando...
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
CORDEIRO, Maiara Mikuska
RIBEIRO, Rosane Aparecida
BUBNA, Patricia Biscaia
ALMEIDA, Any Caroline de
FRANCO, Gilson Cesar Nobre
SCOMPARIN, Dionizia Xavier
Citação
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, v.49, n.6, p.633-642, 2022
Resumo
Physical inactivity, associated with the ingestion of hypercaloric foods, contributes to obesity development. In contrast, physical exercise training (ET) can slow obesity progression. Vitamin (Vit) D, a hormone that regulates adipocyte metabolism, may represent a strategy to reduce obesity; however, it is currently not known whether Vit D enhances the anti-obesity benefits of physical exercise. We hypothesized that swimming ET may prevent Western diet (WD)-induced obesity, and that Vit D supplementation could enhance the anti-obesity actions of ET. Male Wistar rats were fed, from 21 to 90 days of age, on a standard diet, or a WD, in association or not (sedentary control [CTL-SED] and WD [WD-SED] groups) with swimming ET for 15 min/day, 3 days a week (exercised CTL [CTL-EXE] and WD [WD-EXE] groups). Additionally, at 60 days of age, half of the CTL-EXE and WD-EXE groups were submitted, or not, to oral Vit D supplementation (CTL-EXE-VD and WD-EXE-VD groups, respectively). At 91 days old, WD-SED rats displayed increased body weight, abdominal adiposity, hypercholesterolemia, hyperleptinaemia and high circulating levels of tumour necrosis factor (TNF)-alpha. Swimming ET attenuated the increase in abdominal adiposity induced by WD. Furthermore, the WD-EXE group exhibited reductions in glycaemia, triglyceridaemia, cholesterolaemia, leptinaemia and in plasma TNF-alpha concentrations. Vitamin D supplementation, combined with ET, did not provide any additive benefit against adiposity, only potentiating the effects of ET action on the reduction in triglyceridaemia. Exercise training, independently of Vit D, provides a strategy to attenuate the adiposity expansion that is induced by WD, mediated in part by reductions in leptinaemia and TNF-alpha levels.
Palavras-chave
adipokines, cholecalciferol, exercise training, obesity, swimming, Western diet
Referências
- Acar H, 2020, PROG NUTR, V22, P146, DOI 10.23751/pn.v22i1.7835
- Anderson E., 2019, SPORTS MED HLTH SCI, V1, P3, DOI [10.1016/j.smhs.2019.08.006, DOI 10.1016/J.SMHS.2019.08.006]
- Blumberg JM, 2006, J BIOL CHEM, V281, P11205, DOI 10.1074/jbc.M510343200
- Booth FW, 2017, PHYSIOL REV, V97, P1351, DOI 10.1152/physrev.00019.2016
- Borges CC, 2018, J NUTR SCI VITAMINOL, V64, P106, DOI 10.3177/jnsv.64.106
- Souza MVC, 2014, CLINICS, V69, P265, DOI 10.6061/clinics/2014(04)08
- Carrelli A, 2017, J BONE MINER RES, V32, P237, DOI 10.1002/jbmr.2979
- Chang E, 2016, NUTRITION, V32, P702, DOI 10.1016/j.nut.2015.12.032
- Cho Jinkyung, 2014, J Exerc Nutrition Biochem, V18, P339, DOI 10.5717/jenb.2014.18.4.339
- Cordeiro MM, 2021, LIFE SCI, V278, DOI 10.1016/j.lfs.2021.119550
- Da Silva Jr JA., 2020, AN ACAD BRAS CIENC, V92
- Dibaba DT, 2019, NUTR REV, V77, P890, DOI 10.1093/nutrit/nuz037
- Didek D, 2019, BRAZ ARCH BIOL TECHN, V62, DOI 10.1590/1678-4324-2019180563
- Gobatto CA, 2001, COMP BIOCHEM PHYS A, V130, P21, DOI 10.1016/S1095-6433(01)00362-2
- Gullu E, 2020, PROG NUTR, V22, P177, DOI 10.23751/pn.v22i1.8846
- Guthold R, 2018, LANCET GLOB HEALTH, V6, pE1077, DOI [10.1016/S2214-109X(18)30357-7, 10.1016/s2214-109x(18)30357-7]
- Hengist A, 2019, NUTR BULL, V44, P25, DOI 10.1111/nbu.12369
- Hossein-nezhad A, 2013, MAYO CLIN PROC, V88, P720, DOI 10.1016/j.mayocp.2013.05.011
- Hristov M, 2020, ACTA HISTOCHEM, V122, DOI 10.1016/j.acthis.2020.151616
- Hristov M, 2019, AMINO ACIDS, V51, P1055, DOI 10.1007/s00726-019-02746-x
- Jamka M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16142
- Kaneko I, 2015, FASEB J, V29, P4023, DOI 10.1096/fj.14-269811
- Kang EJ, 2015, INT J MOL MED, V36, P1151, DOI 10.3892/ijmm.2015.2300
- Kirchgessner TG, 1997, J CLIN INVEST, V100, P2777, DOI 10.1172/JCI119824
- Lee Youngjeon, 2012, Lab Anim Res, V28, P171, DOI 10.5625/lar.2012.28.3.171
- Lonnqvist F, 1997, J CLIN INVEST, V99, P2398, DOI 10.1172/JCI119422
- Lu Y, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0263-y
- Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881
- Mazzone G, 2018, UNITED EUR GASTROENT, V6, P1056, DOI 10.1177/2050640618774140
- Oh KS, 2007, EXP MOL MED, V39, P385, DOI 10.1038/emm.2007.43
- Oosterwerff MM, 2014, ENDOCR CONNECT, V3, DOI 10.1530/EC-14-0096
- Pasman WJ, 1998, AM J PHYSIOL-ENDOC M, V274, pE280, DOI 10.1152/ajpendo.1998.274.2.E280
- Plut C, 2003, J PHARMACOL EXP THER, V307, P544, DOI 10.1124/jpet.103.054726
- Plut C, 2002, J PHARMACOL EXP THER, V302, P525, DOI 10.1124/jpet.302.2.525
- Popa C, 2005, ANN RHEUM DIS, V64, P303, DOI 10.1136/ard.2004.023119
- Ranallo RF, 1998, SPORTS MED, V26, P29, DOI 10.2165/00007256-199826010-00003
- Ribeiro RA, 2014, HORM METAB RES, V46, P609, DOI 10.1055/s-0034-1368705
- Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18
- Scomparin DX, 2011, ENDOCR RES, V36, P83, DOI 10.3109/07435800.2010.534750
- Nogueira PAS, 2017, J EXERC REHABIL, V13, P284, DOI 10.12965/jer.1734944.472
- Simental-Mendia Luis E., 2008, Metabolic Syndrome and Related Disorders, V6, P299, DOI 10.1089/met.2008.0034
- Spanakis E, 2006, J RHEUMATOL, V33, P2440
- Sundari LPR, 2020, CURR RES NUTR FOOD S, V8, P541, DOI 10.12944/CRNFSJ.8.2.20
- TERAO T, 1989, Tokai Journal of Experimental and Clinical Medicine, V14, P139
- Thompson D, 2012, PHYSIOL REV, V92, P157, DOI 10.1152/physrev.00012.2011
- Vis M, 2005, J RHEUMATOL, V32, P252
- Wang HM, 2017, AGING DIS, V8, P346, DOI 10.14336/AD.2016.1021
- Wicinski M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112826
- Zhang GZ, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/5940732